| 2021 | Nicotine Dependence and Stress Susceptibility in E-Cigarette Smokers: The Korea National Health and Nutrition Examination Survey 2013-2017
| TUBERCULOSIS AND RESPIRATORY DISEASES |
| 1999 | Nicotine과 NNK가 치은 섬유아세포에 미치는 영향 | Dissertation |
| 1998 | Nicotine과 NNK가 치은 섬유아세포에 미치는 영향
| Journal of Korean Academy of Periodontology (대한치주과학회지) |
| 1967 | Nicotine이 cholesterol 食餌性 家兎動脈硬化症에 미치는 影響 | Dissertation |
| 1997 | NICU 소음이 미숙아의 생리적 반응과 행동 상태에 미치는 영향 | Thesis |
| 2008 | NICU 신규간호사 시청각 교육자료 개발을 위한 pilot 연구
| Thesis |
| 1990 | Nifedipine 및 Reserpine이 Cardiomyopathic Syrian Hamster의 심근미세혈관에 미치는 영향 | Dissertation |
| 2011 | Niflumic Acid Reduces Histamine-Induced MUC5AC Expression in Human Conjunctival Epithelial Cells | OPHTHALMIC RESEARCH |
| 2023 | Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease | EUROPEAN JOURNAL OF NEUROLOGY |
| 2015 | Nigrostriatal dopamine-independent resting-state functional networks in Parkinson's disease | NEUROIMAGE |
| 2000 | NIH 3T3 세포에서 anisomycin 유도 세포사멸시 pip92 발현의 신호변환경로 | Thesis |
| 2008 | NIH/3T3 세포에서 nitric oxide에 의해 유도되는 단백체
| Thesis |
| 1989 | Nimodipine이 쥐의 뇌경색에 미치는 영향 | Dissertation |
| 2010 | Nine Polypedilum Species (Diptera, Chironomidae) New to Korea Collected Near Namdae-stream, Muju
| Korean Journal of Systematic Zoology (한국동물분류학회지) |
| 2013 | Nine-Month Angiographic and Intravascular Ultrasound Outcomes After Resolute Zotarolimus-Eluting Stent Implantation for the Treatment of In-Stent Restenosis | JOURNAL OF INTERVENTIONAL CARDIOLOGY |
| 2006 | Nine-year survival of lymphoblastic lymphoma patients
| YONSEI MEDICAL JOURNAL |
| 2014 | Nineteen-year oncologic outcomes and the benefit of elective neck dissection in salivary gland adenoid cystic carcinoma. | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
| 2018 | Nipple-areolar complex ischemia and necrosis in nipple-sparing mastectomy | EJSO |
| 2011 | Nipple-areolar complex reconstruction: systematic approach
| JOURNAL OF THE KOREAN MEDICAL ASSOCIATION |
| 2022 | Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
| LANCET ONCOLOGY |
